Bispecifics in Oncology and IO: Anything One Can Do, Can Two Do Better?
In this webinar, scientific and business development experts discuss the science and business of bispecifics and related multivalent cancer therapeutics.
Join us as we explore scientific issues in technology:
- Clinical opportunities for developing multivalent biologics platforms.
- Pros and cons of such bispecifics for improving the management of patients.
- Licensing and commercial strategies.
